A new study found that β2 adrenergic receptor signaling negatively regulates autophagy, promotes HIF-1α stabilization, and reprograms glucose metabolism in HCC cells, leading to sorafenib resistance (265–267). This evidence concerns the gene HIF1A and hepatocellular carcinoma.